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Serum antibody formation in response to a
primary antigenic stimulation may be blocked
by the concomitant administration of one of a
number of cellular poisons. X-ray, nitrogen mus-
tard and 6-mercaptopurine are better known
examples of such inhibiting agents (1, 2, 3). Block-
ade may be partial or complete depending on
agent, dosage schedule and time relation to anti-
gen injection (4). The blocking effect cannot be
demonstrated with all cytotoxic agents; it would
seem to belong rather uniquely to that group of
materials which specifically depress nucleic acid
synthesis. Many agents of this group have proved
useful in cancer therapy and, in fact, this property
of inhibiting antibody formation has been pro-
posed as a screening test for anti-cancer drugs (5).
Cyclophosphoramidel is a relatively new nitro-
gen mustard. Unreactive and non-irritating in
its native state, it is activated by phosphorami-
dase—a ubiquitous cellular enzyme that tends to
occur in high concentration in tumor tissue. The
activated molecule behaves as a nitrogen mustard,
agranulocytosis being one of its prominent phar-
macological effects.
The guinea-pig is a most useful subject for the
study of delayed hypersensitivity (allergic con-
tact dermatitis, tuberculin allergy). Of its im-
mediate-type serum antibody systems, anaphy-
laxis is the most easily reproducible and serves
as a model for such systems in that animal.
As the first part of an investigation of the in-
fluence of cyclophosphoramide on immunological
reactions (both immediate and delayed type) we
have explored the possible effect of this drug on
the acquisition of anaphylactic sensitivity in the
guinea pig.
EXPERIMENTAL
Stock outbred albino guinea-pigs weighing
approximately 400 grams were given daily intra-
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peritoneal injections of cyclophosphoramide
according to the following 8-day schedule: 15
mgm/d. X 2 d., 10 mgm/d. X 6 d. With this regi-
men the peripheral white blood cell count begins
dropping on the 4th or 5th day and decreases to
less than 1000 in the next few days. A week to 10
days following the last cyclophosphoramide in-
jection the peripheral blood count has returned
to normal (about 10,000). Associated with this
dosage schedule the guinea pigs are sick and show
a mortality of 15—40%.
Intraperitoneal ovalbumin (10 mgm.) was given
to the experimental animals on the 1st day (Group
I) or the 2nd day (Group II) after the start of the
cyclophosphoramide. Control animals received
the same single injection of ovalbumin but no
cyclophosphoramide. Twenty-one days later an
anaphylactically eliciting dose of egg albumin
(2 mgm.) was injected into the heart. Immediate
death in anaphylactic shock provided a crisp
qualitative end-point.
RESULTS
Our results are shown in Table I (animals that
died before the experiment's completion are ex-
cluded). It is clear that the prior administration
of cyclophosphoramide inhibited the formation
of anaphylactic antibody. This was not a non-
specific inhibition arising from the toxic state of
the animals; many poisons such as sodium cy-
anide, even in LD50 dosage schedules, fail to
diminish circulating antibody formation in experi-
mental animals. (6) Further, it is a well-known
clinical fact that severe and terminal sickness
per se does not interfere with serum antibody
formation.
It would seem that this immunological blockade
by cyclophosphoramide proceeds via a profound
and specific depression of the nucleic acid metabo-
lism of the antibody forming machinery at a time
when its metabolism would otherwise be acceler-
ated by antigenic stimulation (7).
TABLE I
Total animals Anaphylaais Survivors
Groupl
Group II
Controls
7
16
23
1
0
20
6
16
3
235
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SUMMARY
Cyelophosphoramide (Cytoxan®), a nitrogen
mustard, inhibits primary anaphylactic sensiti-
zation in the guinea pig.
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